furosemide has been researched along with Chronic Kidney Diseases in 44 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This subanalysis investigated the effect of add-on TLV compared to increased furosemide (FUR) on both electrolyte-free water and electrolyte clearance in patients with congestive heart failure (CHF) complicated by advanced chronic kidney disease (CKD)." | 9.27 | Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study. ( Akashi, YJ; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y; Tominaga, N, 2018) |
| "Treatment of congestive heart failure (CHF) with loop diuretics, such as furosemide, may be associated with complications, including worsening renal function and metabolic or electrolyte disturbances." | 9.20 | Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
| "Furosemide, a loop diuretic, is often empirically used to treat acute decompensated heart failure (ADHF) initially." | 8.31 | Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure. ( Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y, 2023) |
| "A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss." | 5.51 | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease. ( Akimoto, T; Kobayashi, T; Maeshima, A; Masuda, T; Matsuoka, R; Murakami, T; Muto, S; Nagata, D; Nagayama, I; Nakagawa, S; Ohara, K; Saito, O, 2019) |
| " This study suggests that chronic administration of captopril, but not furosemide, could be beneficial in patients with HFpEF, particularly in those with comorbidities such as obesity, diabetes, and dyslipidemias." | 5.48 | Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction. ( Bastacky, SI; Jackson, EK; Salah, EM; Tofovic, SP, 2018) |
| " This subanalysis investigated the effect of add-on TLV compared to increased furosemide (FUR) on both electrolyte-free water and electrolyte clearance in patients with congestive heart failure (CHF) complicated by advanced chronic kidney disease (CKD)." | 5.27 | Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study. ( Akashi, YJ; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y; Tominaga, N, 2018) |
| "Treatment of congestive heart failure (CHF) with loop diuretics, such as furosemide, may be associated with complications, including worsening renal function and metabolic or electrolyte disturbances." | 5.20 | Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
| "Furosemide, a loop diuretic, is often empirically used to treat acute decompensated heart failure (ADHF) initially." | 4.31 | Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure. ( Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y, 2023) |
| "To ascertain whether increasing doses of orally administered furosemide are associated with impaired survival in outpatients with chronic heart failure (CHF) and left ventricular (LV) systolic dysfunction." | 3.79 | Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. ( Cicoira, M; Dini, FL; Genta, FT; Ghio, S; Klersy, C; Rossi, A; Scelsi, L; Simioniuc, A; Tavazzi, L; Temporelli, PL, 2013) |
| "In this study, 30 patients with chronic systolic heart failure in a presumed euvolemic state and on standard oral furosemide therapy (40 to 80 mg) were examined." | 3.77 | Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. ( Collinson, PO; Damman, K; Gaze, D; Hillege, HL; Lip, GY; MacFadyen, RJ; Ng Kam Chuen, MJ; van Oeveren, W; van Veldhuisen, DJ; Voors, AA, 2011) |
| " Veverimer is not systemically absorbed, so potential drug-drug interactions (DDIs) are limited to effects on the absorption of other oral drugs through binding to veverimer in the gastrointestinal tract or increases in gastric pH caused by veverimer binding to hydrochloric acid." | 3.01 | Assessment of the Potential for Veverimer Drug-Drug Interactions. ( Biyani, K; Guttendorf, R; Klaerner, G; Lee, A; Li, E; Mathur, V; Parsell, D; Shao, J; Stasiv, Y; Tabakman, S; Tsao, L; Wu, YS, 2021) |
| "The furosemide stress test has been demonstrated to be a useful clinical tool to ascertain tubular integrity in the setting of acute kidney injury." | 2.55 | Use of stress tests in evaluating kidney disease. ( Chawla, LS; Koyner, JL, 2017) |
| "Furosemide is a widely used, potent natriuretic drug, which inhibits the Na(+)-K(+)-2Cl(-) cotransporter (NKCC)-2 in the ascending limb of the loop of Henle applied to reduce extracellular fluid volume expansion in heart and kidney disease." | 2.53 | Everything we always wanted to know about furosemide but were afraid to ask. ( Braam, B; Dorhout Mees, E; Hamza, S; Huang, X; Vos, P, 2016) |
| "Hyperuricemia is common among patients with chronic kidney disease (CKD)." | 1.72 | Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease. ( Coelho, VA; Costa, TEM; Elias, RM; Innecchi, MLR; Lauar, JC; Moysés, RMA, 2022) |
| "A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss." | 1.51 | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease. ( Akimoto, T; Kobayashi, T; Maeshima, A; Masuda, T; Matsuoka, R; Murakami, T; Muto, S; Nagata, D; Nagayama, I; Nakagawa, S; Ohara, K; Saito, O, 2019) |
| " This study suggests that chronic administration of captopril, but not furosemide, could be beneficial in patients with HFpEF, particularly in those with comorbidities such as obesity, diabetes, and dyslipidemias." | 1.48 | Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction. ( Bastacky, SI; Jackson, EK; Salah, EM; Tofovic, SP, 2018) |
| "Furosemide was considered a long-term therapy for almost all patients (98." | 1.46 | Potentially inappropriate use of furosemide in a very elderly population: An observational study. ( Asgassou, S; d'Athis, P; Dipanda, M; Guepet, H; Manckoundia, P; Mazen, E; Menu, D; Perrin, S; Putot, A; Rodriguez-Cillero, C, 2017) |
| "In total, 3252 Chronic Renal Insufficiency Cohort participants with at least one study electrocardiogram between 2003 and 2011 were included." | 1.46 | Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. ( Delafontaine, P; Deo, R; Doerfler, RM; Fink, JC; Fischer, MJ; Jaar, BG; Kramlik, S; Makos, GK; Navaneethan, S; Ojo, A; Slaven, A; Snitker, S; Soliman, EZ; St Peter, WL; Weir, MR; Zhan, M, 2017) |
| "Furosemide test is a simple and useful test of renal physiology usually used for evaluating the capability of the collecting ducts to secrete potassium under the effect of this drug." | 1.39 | Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus. ( De Miguel, R; Giordani, C; Groppa, R; Imperiali, N; Martinez, B; Mombelli, C; Musso, CG; Navarro, M, 2013) |
| "These disorders are called pseudo-Bartter syndrome." | 1.36 | [Pseudo-Bartter syndrome--2 cases]. ( Baranowicz-Gaszczyk, I; Borowicz, E; Jaroszyński, A; Jóźwiak, L; Ksiazek, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (6.82) | 29.6817 |
| 2010's | 33 (75.00) | 24.3611 |
| 2020's | 8 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, TEM | 1 |
| Lauar, JC | 1 |
| Innecchi, MLR | 1 |
| Coelho, VA | 1 |
| Moysés, RMA | 2 |
| Elias, RM | 3 |
| Komiya, S | 1 |
| Katsumata, M | 1 |
| Ozawa, M | 1 |
| Haze, T | 1 |
| Kawano, R | 1 |
| Ohki, Y | 1 |
| Suzuki, S | 1 |
| Kobayashi, Y | 1 |
| Fujiwara, A | 1 |
| Saka, S | 1 |
| Tamura, K | 1 |
| Hirawa, N | 1 |
| Hamdy, MM | 1 |
| Abdel-Rahman, MS | 1 |
| Badary, DM | 1 |
| Sabra, MS | 1 |
| Tagaya, T | 1 |
| Hayashi, H | 1 |
| Ogata, S | 1 |
| Takahashi, K | 1 |
| Koide, S | 1 |
| Inaguma, D | 1 |
| Hasegawa, M | 1 |
| Yuzawa, Y | 1 |
| Tsuboi, N | 1 |
| Rivero, J | 1 |
| Rodríguez, F | 1 |
| Soto, V | 1 |
| Macedo, E | 1 |
| Chawla, LS | 2 |
| Mehta, RL | 1 |
| Vaingankar, S | 1 |
| Garimella, PS | 1 |
| Garza, C | 1 |
| Madero, M | 1 |
| Mihaila, SM | 1 |
| Faria, J | 1 |
| Stefens, MFJ | 1 |
| Stamatialis, D | 1 |
| Verhaar, MC | 1 |
| Gerritsen, KGF | 1 |
| Masereeuw, R | 1 |
| Hu, M | 1 |
| Yan, G | 1 |
| Tang, H | 1 |
| Wang, L | 1 |
| Zhang, Q | 1 |
| Gong, J | 1 |
| Tang, C | 1 |
| Parsell, D | 1 |
| Shao, J | 1 |
| Guttendorf, R | 1 |
| Mathur, V | 1 |
| Li, E | 1 |
| Wu, YS | 1 |
| Tsao, L | 1 |
| Tabakman, S | 1 |
| Stasiv, Y | 1 |
| Lee, A | 1 |
| Biyani, K | 1 |
| Klaerner, G | 1 |
| Momomura, SI | 1 |
| Rodriguez-Cillero, C | 1 |
| Menu, D | 1 |
| d'Athis, P | 1 |
| Perrin, S | 1 |
| Dipanda, M | 1 |
| Asgassou, S | 1 |
| Guepet, H | 1 |
| Mazen, E | 1 |
| Manckoundia, P | 1 |
| Putot, A | 1 |
| Snitker, S | 1 |
| Doerfler, RM | 1 |
| Soliman, EZ | 1 |
| Deo, R | 1 |
| St Peter, WL | 1 |
| Kramlik, S | 1 |
| Fischer, MJ | 1 |
| Navaneethan, S | 1 |
| Delafontaine, P | 1 |
| Jaar, BG | 1 |
| Ojo, A | 1 |
| Makos, GK | 1 |
| Slaven, A | 1 |
| Weir, MR | 1 |
| Zhan, M | 1 |
| Fink, JC | 1 |
| Shah, R | 1 |
| Wood, SJ | 1 |
| Khan, SA | 1 |
| Chaudhry, A | 1 |
| Rehan Khan, M | 1 |
| Morsy, MS | 1 |
| Salah, EM | 1 |
| Bastacky, SI | 1 |
| Jackson, EK | 1 |
| Tofovic, SP | 1 |
| Tominaga, N | 2 |
| Kida, K | 2 |
| Inomata, T | 1 |
| Sato, N | 1 |
| Izumi, T | 1 |
| Akashi, YJ | 2 |
| Shibagaki, Y | 2 |
| Bolt, LJJ | 1 |
| Sigterman, TA | 1 |
| Krasznai, AG | 1 |
| Sikkink, CJM | 1 |
| Schurink, GH | 1 |
| Bouwman, LH | 1 |
| Ohara, K | 2 |
| Masuda, T | 2 |
| Murakami, T | 2 |
| Imai, T | 1 |
| Yoshizawa, H | 1 |
| Nakagawa, S | 2 |
| Okada, M | 1 |
| Miki, A | 1 |
| Myoga, A | 1 |
| Sugase, T | 1 |
| Sekiguchi, C | 1 |
| Miyazawa, Y | 1 |
| Maeshima, A | 2 |
| Akimoto, T | 2 |
| Saito, O | 2 |
| Muto, S | 2 |
| Nagata, D | 2 |
| Prasad, PV | 2 |
| Li, LP | 2 |
| Thacker, JM | 2 |
| Li, W | 2 |
| Hack, B | 1 |
| Kohn, O | 1 |
| Sprague, SM | 2 |
| Sweetser, S | 1 |
| Clark, JE | 1 |
| de la Fuente, J | 1 |
| Hafdahl, LT | 1 |
| Nagayama, I | 1 |
| Matsuoka, R | 1 |
| Kobayashi, T | 1 |
| Watrobska-Swietlikowska, D | 1 |
| Pietka, M | 1 |
| Klek, S | 1 |
| Dini, FL | 1 |
| Ghio, S | 1 |
| Klersy, C | 1 |
| Rossi, A | 1 |
| Simioniuc, A | 1 |
| Scelsi, L | 1 |
| Genta, FT | 1 |
| Cicoira, M | 1 |
| Tavazzi, L | 1 |
| Temporelli, PL | 1 |
| Okamoto, Y | 1 |
| Nohmi, T | 1 |
| Seki, K | 1 |
| Higa, Y | 1 |
| Pruijm, M | 3 |
| Hofmann, L | 2 |
| Piskunowicz, M | 3 |
| Muller, ME | 1 |
| Zweiacker, C | 1 |
| Bassi, I | 3 |
| Vogt, B | 2 |
| Stuber, M | 3 |
| Burnier, M | 3 |
| Zuercher, E | 1 |
| Milani, B | 2 |
| Narkiewicz, K | 1 |
| Lucisano, G | 1 |
| Simeoni, M | 1 |
| Comi, N | 1 |
| Citraro, ML | 1 |
| Fuiano, L | 1 |
| Fuiano, G | 1 |
| Matsumoto, N | 1 |
| Miyake, F | 1 |
| Kimura, K | 1 |
| Zhou, Y | 1 |
| Usmiani, T | 1 |
| Andreis, A | 1 |
| Budano, C | 1 |
| Sbarra, P | 1 |
| Andriani, M | 1 |
| Garrone, P | 1 |
| Fanelli, AL | 1 |
| Calcagnile, C | 1 |
| Bergamasco, L | 1 |
| Biancone, L | 1 |
| Marra, S | 1 |
| Huang, X | 1 |
| Dorhout Mees, E | 1 |
| Vos, P | 1 |
| Hamza, S | 1 |
| Braam, B | 1 |
| Chehade, H | 1 |
| Ansaloni, A | 1 |
| Anex, C | 1 |
| Cachat, F | 1 |
| Vasco, RF | 1 |
| Moyses, RM | 1 |
| Zatz, R | 1 |
| Koyner, JL | 1 |
| Majumdar, SR | 1 |
| Kjellstrand, CM | 1 |
| Tymchak, WJ | 1 |
| Hervas-Malo, M | 1 |
| Taylor, DA | 1 |
| Teo, KK | 1 |
| Jóźwiak, L | 1 |
| Jaroszyński, A | 1 |
| Baranowicz-Gaszczyk, I | 1 |
| Borowicz, E | 1 |
| Ksiazek, A | 1 |
| Lemes, HP | 1 |
| Araujo, S | 1 |
| Nascimento, D | 1 |
| Cunha, D | 1 |
| Garcia, C | 1 |
| Queiroz, V | 1 |
| Ferreira-Filho, SR | 1 |
| Aziz, EF | 1 |
| Kukin, M | 1 |
| Javed, F | 1 |
| Pratap, B | 1 |
| Sabharwal, MS | 1 |
| Tormey, D | 1 |
| Frankenberger, O | 1 |
| Herzog, E | 1 |
| Gottlieb, SS | 1 |
| Damman, K | 1 |
| Ng Kam Chuen, MJ | 1 |
| MacFadyen, RJ | 1 |
| Lip, GY | 1 |
| Gaze, D | 1 |
| Collinson, PO | 1 |
| Hillege, HL | 1 |
| van Oeveren, W | 1 |
| Voors, AA | 1 |
| van Veldhuisen, DJ | 1 |
| Phakdeekitcharoen, B | 1 |
| Boonyawat, K | 1 |
| Musso, CG | 1 |
| Navarro, M | 1 |
| Mombelli, C | 1 |
| Giordani, C | 1 |
| Groppa, R | 1 |
| Martinez, B | 1 |
| De Miguel, R | 1 |
| Imperiali, N | 1 |
| Abbasi, AH | 1 |
| Ramadan, R | 1 |
| Hoffman, A | 1 |
| Abassi, Z | 1 |
| Sanjay, S | 1 |
| Annigeri, RA | 1 |
| Seshadri, R | 1 |
| Rao, BS | 1 |
| Prakash, KC | 1 |
| Mani, MK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Furosemide Stress Test as a Predictor of Tubular Atrophy and Interstitial Fibrosis in Patients With Chronic Kidney Disease[NCT02417883] | Phase 3 | 100 participants (Anticipated) | Interventional | 2015-04-30 | Recruiting | ||
| Prevention of Contrast-Induced Nephropathy: a Randomized Controlled Trial of Saline + Furosemide + Mannitol in High Risk Patients Undergoing Cardiac Angiography[NCT00175227] | 200 participants (Anticipated) | Interventional | 1996-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for furosemide and Chronic Kidney Diseases
| Article | Year |
|---|---|
High-volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast-induced nephropathy: A meta-analysis of randomized trials.
Topics: Contrast Media; Coronary Angiography; Diuresis; Diuretics; Furosemide; Humans; Prognosis; Randomized | 2017 |
Abdominal Wall Pain: A Common Clinical Problem.
Topics: Abdominal Pain; Abdominal Wall; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Gluconate; D | 2019 |
[Planning of cardiothoracic surgery for chronic kidney disease patients].
Topics: Acute Kidney Injury; Aortic Aneurysm; Atrial Natriuretic Factor; Cardiopulmonary Bypass; Cardiovascu | 2013 |
Everything we always wanted to know about furosemide but were afraid to ask.
Topics: Animals; Blood Pressure; Carbonic Anhydrase Inhibitors; Drug Resistance; Furosemide; GABA-A Receptor | 2016 |
Use of stress tests in evaluating kidney disease.
Topics: Acute Kidney Injury; Furosemide; Glomerular Filtration Rate; Humans; Kidney Function Tests; Kidney G | 2017 |
Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Topics: Acute Kidney Injury; Adult; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Diur | 2009 |
Kidney-ear axis.
Topics: Antineoplastic Agents; Branchio-Oto-Renal Syndrome; Carrier Proteins; Cisplatin; Comorbidity; Diuret | 2007 |
10 trials available for furosemide and Chronic Kidney Diseases
| Article | Year |
|---|---|
Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2022 |
Assessment of the Potential for Veverimer Drug-Drug Interactions.
Topics: Absorption, Physicochemical; Acidosis; Administration, Oral; Adolescent; Adult; Aspirin; Cross-Over | 2021 |
Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Diuretics; Female; Furosemide; H | 2018 |
Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial.
Topics: Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Combined Modality Therapy; Contrast | 2018 |
Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Press | 2015 |
AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Creatinine; Fema | 2016 |
Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Topics: Acute Kidney Injury; Adult; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Diur | 2009 |
Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis.
Topics: Adult; Diet Records; Diuretics; Female; Furosemide; Humans; Kidney; Kidney Failure, Chronic; Male; M | 2011 |
The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.
Topics: Aged; Albumins; Cross-Over Studies; Diuretics; Drug Synergism; Drug Therapy, Combination; Female; Fu | 2012 |
The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Topics: Adult; Aged; Cross-Over Studies; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate | 2008 |
28 other studies available for furosemide and Chronic Kidney Diseases
| Article | Year |
|---|---|
Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Calcium; Cholecalciferol; Female; Furosemide; Humans; H | 2022 |
Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats.
Topics: Adenine; Animals; Caspase 3; Furosemide; Humans; Kidney Failure, Chronic; Rats; Renal Insufficiency, | 2022 |
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure.
Topics: Acute Disease; Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; F | 2023 |
Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease.
Topics: Adult; Biopsy; Disease Progression; Female; Fibrosis; Furosemide; Humans; Kidney; Kidney Tubules, Pr | 2020 |
Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cell Line; Furosemide; H | 2020 |
Effect of Combining Furosemide With Standard Hydration Therapy on Contrast-Induced Acute Kidney Injury Following Coronary Angiography or Intervention in a High-Risk Population.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Furosemide; Glo | 2021 |
Tolvaptan, Is It a Trump to Worsening Renal Function?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2017 |
Potentially inappropriate use of furosemide in a very elderly population: An observational study.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitor | 2017 |
Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Topics: Age Factors; Aged; Aged, 80 and over; Calcium; Cross-Sectional Studies; Diuretics; Female; Furosemid | 2017 |
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Citalopram; Diab | 2017 |
Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Comorbidity; Disease M | 2018 |
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzhydryl Compounds; Body Composition; Female; Flu | 2019 |
Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney Disease.
Topics: Aged; Cell Hypoxia; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Furosemide; G | 2019 |
66-Year-Old Man With Light-headedness, Chest Pain, and Dyspnea.
Topics: Aged; Calcium; Chest Pain; Diagnosis, Differential; Diuretics; Dizziness; Dyspnea; Furosemide; Human | 2019 |
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; | 2019 |
Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics.
Topics: Administration, Intravenous; Drug Incompatibility; Furosemide; Humans; Hydrogen-Ion Concentration; P | 2019 |
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, D | 2013 |
Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans.
Topics: Administration, Intravenous; Adult; Aged; Case-Control Studies; Cell Hypoxia; Diuretics; Female; Fur | 2014 |
A new technique with high reproducibility to estimate renal oxygenation using BOLD-MRI in chronic kidney disease.
Topics: Aged; Automation; Electronic Data Processing; Female; Furosemide; Glomerular Filtration Rate; Health | 2015 |
Continuous intravenous infusion of furosemide is more effective and safer than coadministration of albumin and furosemide in patients with nephrotic syndrome.
Topics: Aged; Albumins; Diuretics; Drug Therapy, Combination; Female; Furosemide; Glomerulonephritis, Membra | 2015 |
Renal Blood Oxygenation Level-Dependent Magnetic Resonance Imaging: A Sensitive and Objective Analysis.
Topics: Adult; Female; Furosemide; Humans; Kidney; Magnetic Resonance Imaging; Male; Oxygen; Renal Insuffici | 2015 |
Renal tissue oxygenation in children with chronic kidney disease due to vesicoureteral reflux.
Topics: Adolescent; Cell Hypoxia; Female; Furosemide; Humans; Kidney Cortex; Kidney Medulla; Magnetic Resona | 2016 |
Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Calcium; Diuretics; Female; Furosemide; Humans; Hydrochlorothiazide; Hyperp | 2016 |
[Pseudo-Bartter syndrome--2 cases].
Topics: Adult; Bartter Syndrome; Diuretics; Female; Furosemide; Humans; Male; Middle Aged; Renal Insufficien | 2010 |
Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Topics: Aged; Chi-Square Distribution; Cross-Sectional Studies; Emergency Service, Hospital; Female; Furosem | 2011 |
Diuretics: are our ideas based on knowledge?
Topics: Acetylglucosaminidase; Comorbidity; Diuretics; Furosemide; Heart Failure; Hepatitis A Virus Cellular | 2011 |
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Topics: Acetylglucosaminidase; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Comorbidity; Creatinine; | 2011 |
Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus.
Topics: Adolescent; Adult; Aged; Diuretics; Female; Furosemide; Humans; Immunosuppressive Agents; Kidney Fun | 2013 |